tiprankstipranks
Trending News
More News >
Artelo Biosciences Inc (ARTL)
NASDAQ:ARTL
US Market
Advertisement

Artelo Biosciences (ARTL) Income Statement

Compare
517 Followers

Artelo Biosciences Income Statement

Last quarter (Q2 2025), Artelo Biosciences's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Artelo Biosciences's net income was $-3.22M. See Artelo Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 10.11M$ 9.93M$ 10.29M$ 7.44M$ 4.69M
Depreciation and Amortization
$ 0.00$ 0.00$ 2.00K$ -2.00K$ 500.00
EBITDA
$ -10.11M$ -9.93M$ -10.29M$ -7.44M$ -4.71M
Operating Income
$ -10.11M$ -9.93M$ -10.29M$ -7.44M$ -4.69M
Other Income/Expenses
$ 282.00K$ 641.00K$ 204.00K$ 2.00K$ 30.91K
Pretax Income
$ -9.83M$ -9.29M$ -10.08M$ -7.44M$ -4.65M
Net Income
$ -9.83M$ -9.29M$ -10.08M$ -7.44M$ -4.65M
Per Share Metrics
Basic EPS
$ -3.05$ -3.14$ -3.49$ -5.97$ -18.83
Diluted EPS
$ -3.05$ -3.14$ -3.49$ -5.97$ -18.83
Weighted Average Shares Outstanding
3.22M 2.96M 472.00K 207.50K-
Weighted Average Shares Outstanding (Diluted)
3.22M 2.96M 472.17K 207.50K-
Currency in USD

Artelo Biosciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis